| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89166f0641fa9de50abb007ff9f66d99 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-80 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-80 |
| filingDate |
2021-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_125aa20a4cc655254fec69769e967241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9aec5f99264c1d6c68e603f9a48d18d |
| publicationDate |
2022-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022010806-A1 |
| titleOfInvention |
Methods for reducing the interference of drugs that bind therapeutic targets expressed on blood cells in serological assays |
| abstract |
Provided are methods of reducing and/or preventing interference by a drug comprising (i) an antibody Fc region and (ii) a moiety that binds a therapeutic target that is expressed on the surface of blood cells (e.g., red blood cells and/or platelets). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11613564-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11639376-B2 |
| priorityDate |
2020-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |